Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

872
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
872

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of mesoglycan in the acute phase of hemorrhoidal disease, the aCute HaemORrhoidal MEsoglycan Study (CHORMES): A double-blind, randomized controlled trial.

Surgery·2026
Same author

Editorial: Advances in proctology and colorectal surgery, volume II.

Frontiers in surgery·2026
Same author

Laparoscopy: is there still a place in 2026?

Minerva urology and nephrology·2026
Same author

The tack technique for robotic ventral mesh rectopexy: An useful, safe and effective trick using the Hugo RAS™ system.

Updates in surgery·2026
Same author

Early hemodynamic changes following endoscopic sclerotherapy for hemorrhoidal disease assessed by transperineal ultrasound and their relationship with clinical outcomes.

International journal of colorectal disease·2026
Same author

Evaluating the effectiveness of oral phlebotonics for the conservative management of hemorrhoidal disease: insights from the VIVI2022/01/VIVALDI study.

Frontiers in surgery·2026

Related Experiment Video

Updated: Apr 18, 2026

Robot-assisted Partial Splenectomy
08:34

Robot-assisted Partial Splenectomy

Published on: January 2, 2026

1.1K

Robotic-assisted partial nephrectomy: experience on 60 cases.

Guglielmo Zeccolini1, Bernardino de Concilio, Dario Del Biondo

  • 1Department of Urology, San Bassiano Hospital, Bassano del Grappa (Vicenza) - Italy.

Urologia
|January 16, 2015
PubMed
Summary

Robotic-assisted partial nephrectomy (RALPN) offers a safe and effective minimally invasive approach for kidney cancer. This study demonstrates successful outcomes with negative surgical margins and manageable complications.

More Related Videos

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

10.0K
Robot-Assisted Kidney Transplantation
07:30

Robot-Assisted Kidney Transplantation

Published on: July 19, 2021

4.6K

Related Experiment Videos

Last Updated: Apr 18, 2026

Robot-assisted Partial Splenectomy
08:34

Robot-assisted Partial Splenectomy

Published on: January 2, 2026

1.1K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

10.0K
Robot-Assisted Kidney Transplantation
07:30

Robot-Assisted Kidney Transplantation

Published on: July 19, 2021

4.6K

Area of Science:

  • Urology
  • Minimally Invasive Surgery
  • Robotic Surgery

Background:

  • Laparoscopic partial nephrectomy presents surgical challenges, demanding efficient techniques to minimize warm ischemia time (WIT) and bleeding.
  • Achieving negative surgical margins is crucial for complete tumor excision.
  • Robotic-assisted partial nephrectomy (RALPN) leverages advanced systems for enhanced visualization and instrument dexterity.

Purpose of the Study:

  • To report the institutional experience with robotic-assisted partial nephrectomy (RALPN) for kidney cancer.
  • To evaluate the safety and efficacy of RALPN in a clinical setting.

Main Methods:

  • A total of 60 patients with kidney cancer underwent RALPN between August 2009 and October 2012.
  • Procedures were performed using a transperitoneal approach with hilar clamping.
  • Patient demographics included an average age of 63 years, average BMI of 25 kg/m², and average tumor size of 3.2 cm.

Main Results:

  • The mean operative time was 167.2 minutes, with a mean warm ischemia time (WIT) of 23.8 minutes.
  • Mean estimated blood loss was 260 mL.
  • Pathologic examination confirmed clear cell renal cell carcinoma in most cases, with all resection margins free from tumor. Complications included one case requiring nephrectomy, one pulmonary embolism, and one urinary leakage.

Conclusions:

  • Robotic technology facilitates partial nephrectomy, making it a frequently performed, safe, and effective minimally invasive procedure.
  • RALPN enables complete tumor excision with negative margins and acceptable complication rates.